PAVM logo

PAVM PAVmed Inc.

NASDAQ Capital Market · Medical - Devices · Healthcare

$1.14
-0.07 (-5.42%)

PAVmed Inc. operates as a U.S.-based medical technology firm. Its principal commercialized products include CarpX, a percutaneous device designed to address carpal tunnel syndrome. Other key offerings are EsoCheck, an esophageal cell collection device vital for the early detection of esophageal adenocarcinoma and Barrett's Esophagus (BE), and EsoGuard, a specialized bisulfite-converted next-genera…

Market Cap: $9.08Mwww.pavmed.com

Price

No data yet.

Social Signal Score

50
5d
—
30d
50
3 mentions
—
60d
50
3 mentions
—
90d
50
3 mentions
—
news: 3

Analyst Ratings

3 analysts
Buyconsensus
Strong Buy 0Buy 2Hold 1Sell 0Strong Sell 0

Revenue

$41.0K
$0.00$349.7K$699.3K$1.05M
Dec 2016Sep 2026

Analyst Estimates

FY2025
$-3.60
$-3.71–$-3.49
1 analysts
FY2026
$-4.91
$-5.06–$-4.76
1 analysts
FY2027
$-1.28
$-1.32–$-1.24
1 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Lishan Aklog
Sector
Healthcare
Industry
Medical - Devices
Employees
41
Beta
0.54
Country
US
Piotroski score
4 / 9 (Middling)
Altman Z-score
-12.86
www.pavmed.com